TrialSafety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye Disease
Trial details
- Registry ID
- NCT05896670
- Phase
- Phase 2
Drug research
licaminlimab
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
Also recorded as OCS-02
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye DiseaseNCT05896670 | Oculis | Phase 2 | Completed | 2024-03-27Actual |
| A Clinical Study Evaluating Licaminlimab for Dry Eye DiseaseNCT07548632 | Oculis | Phase 2, Phase 3 | Recruiting | 2026-12Estimated |
A Clinical Study Evaluating Licaminlimab for Dry Eye Disease
Trial details
- Registry ID
- NCT07548632
- Phase
- Phase 2, Phase 3
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |